Skip to Content

54 741 (Montelukast sodium (chewable) 5 mg (base))

Pill imprint 54 741 has been identified as Montelukast sodium (chewable) 5 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium (chewable) 5 mg (base) 54 741
Montelukast sodium (chewable) 5 mg (base) 54 741
Montelukast sodium (chewable)
Imprint:
54 741
Strength:
5 mg (base)
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-0289
Inactive Ingredients:
copovidone
ferric oxide red
magnesium stearate
mannitol
microcrystalline cellulose
sodium starch glycolate type A potato
sucralose

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide